Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1951 1
1953 1
1954 1
1955 2
1962 1
1965 1
1970 1
1971 1
1972 1
1975 2
1976 2
1977 5
1978 5
1979 7
1980 1
1981 1
1983 1
1984 1
1985 5
1986 9
1987 6
1988 11
1989 8
1990 9
1991 5
1992 8
1993 8
1994 9
1995 7
1996 12
1997 8
1998 19
1999 10
2000 11
2001 19
2002 11
2003 9
2004 19
2005 17
2006 10
2007 16
2008 19
2009 17
2010 14
2011 11
2012 20
2013 17
2014 14
2015 12
2016 16
2017 7
2018 5
2019 3
2020 9
2021 7
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

437 results

Results by year

Filters applied: . Clear all
Page 1
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.
Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim-Esen B, Atsumi T, Avcin T, Belmont HM, Bertolaccini ML, Branch DW, Carvalheiras G, Casini A, Cervera R, Cohen H, Costedoat-Chalumeau N, Crowther M, de Jesus G, Delluc A, Desai S, De Sancho M, Devreese KM, Diz-Kucukkaya R, Duarte-Garcia A, Frances C, Garcia D, Gris JC, Jordan N, Leaf RK, Kello N, Knight JS, Laskin C, Lee AI, Legault K, Levine SR, Levy RA, Limper M, Lockshin MD, Mayer-Pickel K, Musial J, Meroni PL, Orsolini G, Ortel TL, Pengo V, Petri M, Pons-Estel G, Gomez-Puerta JA, Raimboug Q, Roubey R, Sanna G, Seshan SV, Sciascia S, Tektonidou MG, Tincani A, Wahl D, Willis R, Yelnik C, Zuily C, Guillemin F, Costenbader K, Erkan D; ACR/EULAR APS Classification Criteria Collaborators. Barbhaiya M, et al. Arthritis Rheumatol. 2023 Oct;75(10):1687-1702. doi: 10.1002/art.42624. Epub 2023 Aug 28. Arthritis Rheumatol. 2023. PMID: 37635643
Rare bleeding disorders.
Peyvandi F, Cattaneo M, Inbal A, De Moerloose P, Spreafico M. Peyvandi F, et al. Among authors: de moerloose p. Haemophilia. 2008 Jul;14 Suppl 3:202-10. doi: 10.1111/j.1365-2516.2008.01751.x. Haemophilia. 2008. PMID: 18510543 Review.
Rare bleeding disorders.
Peyvandi F, Bolton-Maggs PH, Batorova A, De Moerloose P. Peyvandi F, et al. Among authors: de moerloose p. Haemophilia. 2012 Jul;18 Suppl 4:148-53. doi: 10.1111/j.1365-2516.2012.02841.x. Haemophilia. 2012. PMID: 22726099 Review.
Congenital fibrinogen disorders.
de Moerloose P, Neerman-Arbez M. de Moerloose P, et al. Semin Thromb Hemost. 2009 Jun;35(4):356-66. doi: 10.1055/s-0029-1225758. Epub 2009 Jul 13. Semin Thromb Hemost. 2009. PMID: 19598064 Review.
Developing and improving the ethical framework for the ISTH.
Zheng Z, Riva N, Scarlatescu E, de Moerloose P, Ariëns R, Amigo MC; ISTH Ethics Committee. Zheng Z, et al. Among authors: de moerloose p. J Thromb Haemost. 2022 Aug;20(8):1753-1754. doi: 10.1111/jth.15780. J Thromb Haemost. 2022. PMID: 35859283 Free article. No abstract available.
Novel products for haemostasis.
Shima M, Hermans C, de Moerloose P. Shima M, et al. Among authors: de moerloose p. Haemophilia. 2014 May;20 Suppl 4:29-35. doi: 10.1111/hae.12413. Haemophilia. 2014. PMID: 24762272 Review.
Fibrinogen and the risk of thrombosis.
de Moerloose P, Boehlen F, Neerman-Arbez M. de Moerloose P, et al. Semin Thromb Hemost. 2010 Feb;36(1):7-17. doi: 10.1055/s-0030-1248720. Epub 2010 Apr 13. Semin Thromb Hemost. 2010. PMID: 20391292 Review.
How I treat dysfibrinogenemia.
Casini A, de Moerloose P. Casini A, et al. Among authors: de moerloose p. Blood. 2021 Nov 25;138(21):2021-2030. doi: 10.1182/blood.2020010116. Blood. 2021. PMID: 33895794 Free article.
Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria.
Barbhaiya M, Zuily S, Ahmadzadeh Y, Amigo MC, Avcin T, Bertolaccini ML, Branch DW, de Jesus G, Devreese KMJ, Frances C, Garcia D, Guillemin F, Levine SR, Levy RA, Lockshin MD, Ortel TL, Seshan SV, Tektonidou M, Wahl D, Willis R, Naden R, Costenbader K, Erkan D; New APS Classification Criteria Collaborators. Barbhaiya M, et al. Arthritis Care Res (Hoboken). 2021 Oct;73(10):1490-1501. doi: 10.1002/acr.24520. Epub 2021 Sep 2. Arthritis Care Res (Hoboken). 2021. PMID: 33253499 Free PMC article. Review.
437 results